Literature DB >> 16734409

Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?

J R Sawyer1, M Husain, O Al-Mefty.   

Abstract

OBJECT: The authors conducted a study of 22 skull base chordomas.
METHODS: A series of 22 skull base chordomas was analyzed with G banding. Subsequently, metaphase cells obtained from three tumors were reexamined using multicolor spectral karyotyping. Clonal chromosome aberrations were identified in 11 cases, all of which were recurrent tumors. Three tumors showed a remarkable similarity in cytogenetic features, and these features appear to characterize a recurring combination of nonrandom chromosome aberrations, including isochromosome 1q, gain of chromosome 7, and monosomy for chromosomes 3, 4, 10,13, and 18. Isochromosome 1q was identified as the sole recurring structural chromosome rearrangement in these tumors. The pattern of chromosome loss reported in the progression of lumbosacral chordoma also appears to be true of skull base chordomas with the additional findings of isochromosome 1q, gain of chromosome 7, and loss of chromosome 18.
CONCLUSIONS: Skull base chordomas characterized by isochromosome 1q and monosomy 13 provide support for the concept of the loss of putative tumor suppressor loci on 1p and 13q and aggressive tumor behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 16734409     DOI: 10.3171/foc.2001.10.3.7

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  11 in total

1.  The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Authors:  Craig Horbinski; Gerard J Oakley; Kathleen Cieply; Geeta S Mantha; Marina N Nikiforova; Sanja Dacic; Raja R Seethala
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

2.  Gain of chromosome 7 by chromogenic in situ hybridization (CISH) in chordomas is correlated to c-MET expression.

Authors:  Beatriz A Walter; Maria Begnami; Vladimir A Valera; Mariarita Santi; Elisabeth J Rushing; Martha Quezado
Journal:  J Neurooncol       Date:  2010-07-10       Impact factor: 4.130

3.  Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33.

Authors:  M J Kelley; J F Korczak; E Sheridan; X Yang; A M Goldstein; D M Parry
Journal:  Am J Hum Genet       Date:  2001-07-10       Impact factor: 11.025

4.  High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.

Authors:  Roberto Jose Diaz; Mustafa Guduk; Rocco Romagnuolo; Christian A Smith; Paul Northcott; David Shih; Fitim Berisha; Adrienne Flanagan; David G Munoz; Michael D Cusimano; M Necmettin Pamir; James T Rutka
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

5.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

6.  Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study.

Authors:  Mauro Longoni; Francesca Orzan; Michela Stroppi; Nicola Boari; Pietro Mortini; Paola Riva
Journal:  Neuro Oncol       Date:  2007-12-19       Impact factor: 12.300

7.  Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literature.

Authors:  Kristopher T Kimmell; Hayan Dayoub; Ethan D Stolzenberg; Eric H Sincoff
Journal:  Surg Neurol Int       Date:  2010-05-31

8.  Frequent activation of EGFR in advanced chordomas.

Authors:  Barbara Dewaele; Francesca Maggiani; Giuseppe Floris; Michele Ampe; Vanessa Vanspauwen; Agnieszka Wozniak; Maria Debiec-Rychter; Raf Sciot
Journal:  Clin Sarcoma Res       Date:  2011-07-25

9.  A vertebral extra dural chordoma at C5, possibly deriving from a clival chordoma.

Authors:  R Goes; J J van Overbeeke
Journal:  Surg Neurol Int       Date:  2015-06-01

10.  Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation.

Authors:  K H Hallor; J Staaf; G Jönsson; M Heidenblad; F Vult von Steyern; H C F Bauer; M Ijszenga; P C W Hogendoorn; N Mandahl; K Szuhai; F Mertens
Journal:  Br J Cancer       Date:  2007-12-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.